{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:01:19Z","timestamp":1791687679422,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"vor","delay-in-days":2503,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1074\/jbc.m113.497990","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T05:37:39Z","timestamp":1379569059000},"page":"31602-31615","source":"Crossref","is-referenced-by-count":78,"title":["Complexes of Trypanosoma cruzi Sterol 14\u03b1-Demethylase (CYP51) with Two Pyridine-based Drug Candidates for Chagas Disease"],"prefix":"10.1016","volume":"288","author":[{"given":"Tatiana Y.","family":"Hargrove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdzislaw","family":"Wawrzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason H.","family":"Chaplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Charman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Waterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Chatelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina I.","family":"Lepesheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M113.497990_bib1","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0022-2275(20)38245-6","article-title":"Mechanistic studies of lanosterol 14\u03b1-methyl demethylase: substrate requirements for the component reactions catalyzed by a single cytochrome P-450 isozyme","volume":"30","author":"Fischer","year":"1989","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.M113.497990_bib2","doi-asserted-by":"crossref","first-page":"13402","DOI":"10.1016\/S0021-9258(18)90709-X","article-title":"Cytochrome P-450-dependent oxidation of lanosterol in cholesterol biosynthesis. Microsomal electron transport and C-32 demethylation","volume":"259","author":"Trzaskos","year":"1984","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.497990_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.mce.2003.11.016","article-title":"CYP51, the omnipotent P450","volume":"215","author":"Lepesheva","year":"2004","journal-title":"Mol. Cell. Endocrinol"},{"key":"10.1074\/jbc.M113.497990_bib4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbagen.2006.07.018","article-title":"Sterol 14\u03b1-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms","volume":"1770","author":"Lepesheva","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.497990_bib5","first-page":"325","year":"1977"},{"key":"10.1074\/jbc.M113.497990_bib6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJM197402072900607","article-title":"Chemotherapy of systemic mycoses","volume":"290","author":"Bennett","year":"1974","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M113.497990_bib7","first-page":"79","year":"1988"},{"issue":"Suppl. 1","key":"10.1074\/jbc.M113.497990_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1470-9465.2004.00841.x","article-title":"History of the development of azole derivatives","volume":"10","author":"Maertens","year":"2004","journal-title":"Clin. Microbiol. Infect"},{"key":"10.1074\/jbc.M113.497990_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/B978-0-12-385863-4.00004-6","article-title":"Targeting Trypanosoma cruzi sterol 14\u03b1-demethylase (CYP51)","volume":"75","author":"Lepesheva","year":"2011","journal-title":"Adv. Parasitol"},{"key":"10.1074\/jbc.M113.497990_bib10","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.333.6045.933","article-title":"Drug developers finally take aim at a neglected disease","volume":"333","author":"Leslie","year":"2011","journal-title":"Science"},{"key":"10.1074\/jbc.M113.497990_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0166-6851(81)90047-5","article-title":"Biochemical and ultrastructural alterations produced by miconazole and econazole in Trypanosoma cruzi","volume":"3","author":"Docampo","year":"1981","journal-title":"Mol. Biochem. Parasitol"},{"key":"10.1074\/jbc.M113.497990_bib12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0006-291X(86)90410-9","article-title":"Effects of ketoconazole on sterol biosynthesis by Trypanosoma cruzi epimastigotes","volume":"136","author":"Beach","year":"1986","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.M113.497990_bib13","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1128\/AAC.32.8.1237","article-title":"Antiproliferative synergism of the allylamine SF 86\u2013327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi","volume":"32","author":"Urbina","year":"1988","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.M113.497990_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.1998.59.133","article-title":"Treatment of chronic Chagas' disease with itraconazole and allopurinol","volume":"59","author":"Apt","year":"1998","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"10.1074\/jbc.M113.497990_bib15","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/45.6.819","article-title":"A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease","volume":"45","author":"Ara\u00fajo","year":"2000","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1074\/jbc.M113.497990_bib16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/AAC.44.1.150-155.2000","article-title":"Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts","volume":"44","author":"Molina","year":"2000","journal-title":"Antimicrob. Agents Chemother"},{"issue":"Suppl. 1","key":"10.1074\/jbc.M113.497990_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1590\/S0074-02762009000900041","article-title":"Ergosterol biosynthesis and drug development for Chagas disease","volume":"104","author":"Urbina","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1074\/jbc.M113.497990_bib18","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/nature09224","article-title":"Chagas disease: pushing through the pipeline","volume":"465","author":"Clayton","year":"2010","journal-title":"Nature"},{"key":"10.1074\/jbc.M113.497990_bib19","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1021\/jm050441z","article-title":"The protein farnesyltransferase inhibitor tipifarnib as a new lead for the development of drugs against Chagas disease","volume":"48","author":"Hucke","year":"2005","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.M113.497990_bib20","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1128\/AAC.06244-11","article-title":"Pharmacological characterization, structural studies, and in vivo activity of anti-Chagas disease lead compounds derived from tipifarnib","volume":"56","author":"Buckner","year":"2012","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.M113.497990_bib21","doi-asserted-by":"crossref","first-page":"15149","DOI":"10.1073\/pnas.2535442100","article-title":"A class of sterol 14-demethylase inhibitors as anti-Trypanosoma cruzi agents","volume":"100","author":"Buckner","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.497990_bib22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/infdis\/jit042","article-title":"VNI cures acute and chronic experimental Chagas disease","volume":"208","author":"Villalta","year":"2013","journal-title":"J. Infect. Dis"},{"key":"10.1074\/jbc.M113.497990_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-6851(02)00280-3","article-title":"Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa","volume":"126","author":"Roberts","year":"2003","journal-title":"Mol. Biochem. Parasitol"},{"key":"10.1074\/jbc.M113.497990_bib24","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1128\/AAC.34.11.2097","article-title":"Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi","volume":"34","author":"Lazardi","year":"1990","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.M113.497990_bib25","doi-asserted-by":"crossref","first-page":"25582","DOI":"10.1074\/jbc.M110.133215","article-title":"Structural insights into inhibition of sterol 14\u03b1-demethylase in the human pathogen Trypanosoma cruzi","volume":"285","author":"Lepesheva","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.497990_bib26","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.chembiol.2007.10.011","article-title":"Sterol 14\u03b1-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth","volume":"14","author":"Lepesheva","year":"2007","journal-title":"Chem. Biol"},{"key":"10.1074\/jbc.M113.497990_bib27","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s11745-008-3225-y","article-title":"CYP51: a major drug target in the cytochrome P450 superfamily","volume":"43","author":"Lepesheva","year":"2008","journal-title":"Lipids"},{"key":"10.1074\/jbc.M113.497990_bib28","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1128\/AAC.00070-13","article-title":"In vitro and in vivo studies of the antiparasitic activity of sterol 14\u03b1-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi","volume":"57","author":"Soeiro Mde","year":"2013","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.M113.497990_bib29","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1074\/jbc.M510317200","article-title":"CYP51 from Trypanosoma cruzi: a phyla-specific residue in the B\u2032 helix defines substrate preferences of sterol 14alpha-demethylase","volume":"281","author":"Lepesheva","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.497990_bib30","doi-asserted-by":"crossref","first-page":"10789","DOI":"10.1021\/bi048967t","article-title":"CYP51 from Trypanosoma brucei is obtusifoliol-specific","volume":"43","author":"Lepesheva","year":"2004","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M113.497990_bib31","doi-asserted-by":"crossref","first-page":"26838","DOI":"10.1074\/jbc.M111.237099","article-title":"Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14\u03b1-demethylase (CYP51) from Leishmania infantum","volume":"286","author":"Hargrove","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.497990_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1194\/jlr.M021865","article-title":"Structural complex of sterol 14\u03b1-demethylase (CYP51) with 14\u03b1-methylenecyclopropyl-\u03947\u201324, 25-dihydrolanosterol","volume":"53","author":"Hargrove","year":"2012","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.M113.497990_bib33","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1021\/jm801643b","article-title":"Indomethacin amides as a novel molecular scaffold for targeting Trypanosoma cruzi sterol 14\u03b1-demethylase","volume":"52","author":"Konkle","year":"2009","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.M113.497990_bib34","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1021\/jm400012e","article-title":"Antitrypanosomal lead discovery: identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth","volume":"56","author":"Andriani","year":"2013","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.M113.497990_bib35","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1074\/jbc.M109.067470","article-title":"Crystal structures of Trypanosoma brucei sterol 14\u03b1-demethylase and implications for selective treatment of human infections","volume":"285","author":"Lepesheva","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.497990_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbapap.2010.06.006","article-title":"Structural basis for conservation in the CYP51 family","volume":"1814","author":"Lepesheva","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.497990_bib37","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2174\/156802611796575902","article-title":"Sterol 14\u03b1-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis","volume":"11","author":"Lepesheva","year":"2011","journal-title":"Curr. Top. Med. Chem"},{"key":"10.1074\/jbc.M113.497990_bib38","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1021\/jm2015809","article-title":"Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease","volume":"55","author":"Keenan","year":"2012","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.M113.497990_bib39","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.bmc.2013.01.050","article-title":"Design, structure-activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruzi","volume":"21","author":"Keenan","year":"2013","journal-title":"Bioorg. Med. Chem"},{"key":"10.1074\/jbc.M113.497990_bib40","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1128\/AAC.40.11.2592","article-title":"Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing \u03b2-galactosidase","volume":"40","author":"Buckner","year":"1996","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.M113.497990_bib41","doi-asserted-by":"crossref","first-page":"9091","DOI":"10.1021\/bi034663f","article-title":"Conservation in the CYP51 family. Role of the B\u2032 helix\/BC loop and helices F and G in enzymatic function","volume":"42","author":"Lepesheva","year":"2003","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M113.497990_bib42","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","article-title":"The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature","volume":"239","author":"Omura","year":"1964","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.497990_bib43","doi-asserted-by":"crossref","first-page":"19699","DOI":"10.1074\/jbc.M111.319202","article-title":"Unusual spectroscopic and ligand binding properties of the cytochrome P450-flavodoxin fusion enzyme XplA","volume":"287","author":"Bui","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.497990_bib44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1107\/S0907444905039107","article-title":"The integration of macromolecular diffraction data","volume":"62","author":"Leslie","year":"2006","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M113.497990_bib45","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suite: programs for protein crystallography","volume":"50","author":"Collaborative Computational Project, Number 4","year":"1994","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M113.497990_bib46","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M113.497990_bib47","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1107\/S0907444904023510","article-title":"REFMAC5 dictionary: organisation of prior chemical knowledge and guidelines for its use","volume":"60","author":"Vagin","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M113.497990_bib48","doi-asserted-by":"crossref","first-page":"E101","DOI":"10.1208\/aapsj080112","article-title":"Cytochrome P450s and other enzymes in drug metabolism and toxicity","volume":"8","author":"Guengerich","year":"2006","journal-title":"AAPS J"},{"key":"10.1074\/jbc.M113.497990_bib49","doi-asserted-by":"crossref","first-page":"28413","DOI":"10.1074\/jbc.M102767200","article-title":"Folding requirements are different between sterol 14\u03b1-demethylase (CYP51) from Mycobacterium tuberculosis and human or fungal orthologs","volume":"276","author":"Lepesheva","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.497990_bib50","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpddr.2012.06.001","article-title":"CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffolds","volume":"2","author":"Hargrove","year":"2012","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"key":"10.1074\/jbc.M113.497990_bib51","series-title":"Cytochrome P450: Structure, Mechanism, and Biochemistry","first-page":"246","article-title":"Inhibition of cytochrome P450 enzymes","author":"Correia","year":"2005"},{"key":"10.1074\/jbc.M113.497990_bib52","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/dmd.30.3.314","article-title":"Inhibition of cytochromes P450 by antifungal imidazole derivatives","volume":"30","author":"Zhang","year":"2002","journal-title":"Drug. Metab. Dispos"},{"key":"10.1074\/jbc.M113.497990_bib53","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1124\/jpet.105.093229","article-title":"The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions","volume":"316","author":"Obach","year":"2006","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1074\/jbc.M113.497990_bib54","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/03602530701498455","article-title":"Inhibition of cytochromes P450: existing and new promising therapeutic targets","volume":"39","author":"Schuster","year":"2007","journal-title":"Drug. Metab. Rev"},{"key":"10.1074\/jbc.M113.497990_bib55","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/ACO.0b013e32833a254d","article-title":"Azole antimycotics and drug interactions in the perioperative period","volume":"23","author":"Saari","year":"2010","journal-title":"Curr. Opin. Anaesthesiol"},{"key":"10.1074\/jbc.M113.497990_bib56","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1517\/17425255.2011.627854","article-title":"Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450","volume":"7","author":"Gubbins","year":"2011","journal-title":"Expert Opin. Drug. Metab. Toxicol"},{"key":"10.1074\/jbc.M113.497990_bib57","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1124\/mol.113.085902","article-title":"Antifungal azoles: structural insights into undesired tight binding to cholesterol-metabolizing CYP46A1","volume":"84","author":"Mast","year":"2013","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.M113.497990_bib58","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/524071","article-title":"Resistance to antifungal agents: mechanisms and clinical impact","volume":"46","author":"Kanafani","year":"2008","journal-title":"Clin. Infect. Dis"},{"key":"10.1074\/jbc.M113.497990_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1130-1406(08)70027-5","article-title":"Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi","volume":"25","author":"Espinel-Ingroff","year":"2008","journal-title":"Rev. Iberoam. Micol"},{"key":"10.1074\/jbc.M113.497990_bib60","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1021\/ol303092v","article-title":"Organocatalytic, enantioselective synthesis of VNI: a robust therapeutic development platform for Chagas, a neglected tropical disease","volume":"14","author":"Dobish","year":"2012","journal-title":"Org. Lett"},{"key":"10.1074\/jbc.M113.497990_bib61","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jmb.2010.01.075","article-title":"Structural basis of human CYP51 inhibition by antifungal azoles","volume":"397","author":"Strushkevich","year":"2010","journal-title":"J. Mol. Biol"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582048634X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582048634X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M113.497990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T02:00:56Z","timestamp":1620266456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582048634X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":61,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S002192582048634X"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m113.497990","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}